Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.33 is 41% below its 5-year average of 2.25, near the low end of its 5-year range (1.17–23.87).
As of the fiscal period ended Tuesday, June 30, 2026. 16.97% below its 12-month average of 1.61.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.33.
QUICK RATIO (ACID-TEST)
1.33
QUICK RATIO (ACID-TEST) AVG TTM
1.61
QUICK RATIO (ACID-TEST) AVG 3Y
2.00
QUICK RATIO (ACID-TEST) AVG 5Y
2.25
QUICK RATIO (ACID-TEST) AVG 10Y
8.60
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.97%
CURRENT VS 3Y AVG
-33.16%
CURRENT VS 5Y AVG
-40.62%
CURRENT VS 10Y AVG
-84.49%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-60.19%
vs the sector median at left
Verrica Pharmaceuticals Inc.
Market Cap
$73.57M
Quick Ratio (Acid-Test)
1.33
TTM Avg
1.61
3Y Avg
2.00
5Y Avg
2.25
Market Cap
$71.22M
Quick Ratio (Acid-Test)
4.36
TTM Avg
4.80
3Y Avg
4.58
5Y Avg
6.22
Market Cap
$72.83M
Quick Ratio (Acid-Test)
1.75
TTM Avg
2.29
3Y Avg
2.05
5Y Avg
3.32
Market Cap
$73.81M
Quick Ratio (Acid-Test)
5.45
TTM Avg
4.61
3Y Avg
8.17
5Y Avg
10.19
Market Cap
$69.05M
Quick Ratio (Acid-Test)
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$68.74M
Quick Ratio (Acid-Test)
6.12
TTM Avg
4.89
3Y Avg
4.64
5Y Avg
6.12
Market Cap
$68.10M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$69.04M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
Market Cap
$75.06M
Quick Ratio (Acid-Test)
3.52
TTM Avg
4.58
3Y Avg
5.82
5Y Avg
8.88
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | $73.57M | 1.33 | 1.61 | 2.00 | 2.25 |
| Gain Therapeutics, Inc. (GANX)vs › | $71.22M | 4.36 | 4.80 | 4.58 | 6.22 |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | 1.75 | 2.29 | 2.05 | 3.32 |
| Hyperfine, Inc. (HYPR)vs › | $73.81M | 5.45 | 4.61 | 8.17 | 10.19 |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | 1.03 | 0.95 | 0.86 | 0.95 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.74M | 6.12 | 4.89 | 4.64 | 6.12 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 3.83 | 1.68 | 1.58 | 2.46 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $69.04M | 0.76 | 0.89 | 1.63 | 3.63 |
| Pulmonx Corporation (LUNG)vs › | $75.06M | 3.52 | 4.58 | 5.82 | 8.88 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.24M | 0.14 | 0.07 | 0.07 | 0.07 |
Quick Ratio
1.33
Excludes inventory
Current Ratio
1.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.33 |
| 2026-03-31 | 1.90 |
| 2025-12-31 | 2.45 |
| 2025-09-30 | 1.18 |
| 2025-06-30 | 1.17 |
| 2025-03-31 | 1.26 |
| 2024-12-31 | 1.68 |
| 2024-09-30 | 1.22 |
| 2024-06-30 | 2.23 |
| 2024-03-31 | 3.04 |
| 2023-12-31 | 4.49 |
| 2023-09-30 | 8.04 |
| 2023-06-30 | 9.91 |
| 2023-03-31 | 23.87 |
| 2022-12-31 | 11.31 |
| 2022-09-30 | 14.10 |
| 2022-06-30 | 1.25 |
| 2022-03-31 | 1.47 |
| 2021-12-31 | 1.61 |
| 2021-09-30 | 1.79 |
| 2021-06-30 | 2.06 |
| 2021-03-31 | 2.29 |
| 2020-12-31 | 1.71 |
| 2020-09-30 | 1.90 |
| 2020-06-30 | 2.15 |
| 2020-03-31 | 27.45 |
| 2019-12-31 | 19.39 |
| 2019-09-30 | 17.10 |
| 2019-06-30 | 18.63 |
| 2019-03-31 | 27.65 |
| 2018-12-31 | 36.80 |
| 2018-09-30 | 40.26 |
| 2018-06-30 | 33.47 |
| 2018-03-31 | 17.54 |
| 2017-12-31 | 14.75 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
